The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

The International Prognostic Index and the Follicular Lymphoma International Prognostic Index are widely used for the risk assessment of follicular lymphoma (FL). Although molecular studies have provided insight into the biology of FL, no molecular marker has impacted on treatment stratification. Be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: O'Shea, Derville, O'Riain, Ciarán, Taylor, Claire, Waters, Rachel, Carlotti, Emanuela, MacDougall, Finlay, Gribben, John, Rosenwald, Andreas, Ott, German, Rimsza, Lisa M., Smeland, Erlend B., Johnson, Nathalie, Campo, Elias, Greiner, Timothy C., Chan, Wing C., Gascoyne, Randy D., Wright, George, Staudt, Louis M., Lister, T. Andrew, Fitzgibbon, Jude
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2008
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954748/
https://ncbi.nlm.nih.gov/pubmed/18628487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-05-154013
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge